CQSA
Live / Registered — Registered (as of 10 Feb 2026)
What this means for you
Registered since 10 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98869612
- Registration number
- 8132404
- Mark type
- Stylized text
- Filed
- 23 Nov 2024
- Published for opposition
- 09 Sept 2025
- Registered
- 10 Feb 2026
- Attorney of record
- Duan WU
Goods and services
- Class 042 — Scientific and technological services: Consultancy relating to inspection and monitoring of pharmaceutical manufacturing facilities for quality control and quality assurance purposes; Providing, developing and improving quality control and quality assurance metrics for others in the fields of life sciences, medical devices, pharmaceuticals, over-the-counter drugs, dietary supplements, and combination drug / device products; Consultancy relating to quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of life sciences, medical devices, pharmaceuticals, over-the-counter drugs, dietary supplements, and combination drug / device products
Owner
- James Morris, Quincy, MA, US
- James Morris, Quincy, MA, US
- James Morris, Quincy, MA, US
Prosecution history
- 10 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 18 Jan 2026 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 07 Oct 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION
- 03 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Aug 2025 — EXAMINER'S AMENDMENT ENTERED
- 07 Aug 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 07 Aug 2025 — EXAMINERS AMENDMENT E-MAILED
- 07 Aug 2025 — EXAMINERS AMENDMENT -WRITTEN
- 06 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED